Rigel Pharmaceuticals Appoints Michael P. Miller to Board of Directors
ByAinvest
Tuesday, Feb 3, 2026 8:06 am ET1min read
RIGL--
Rigel Pharmaceuticals has appointed Michael P. Miller to its Board of Directors. Miller has over 40 years of experience in the biotechnology and pharmaceutical industries, with a strong track record of commercial excellence. He will provide valuable insights as Rigel executes its strategic plan, including growing its current portfolio of medicines and evaluating potential in-licensing opportunities.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet